Wang K, Jian X, Xu Z, Wang H (2023) Pre-transplant CRP-albumin ratio as a biomarker in patients receiving haploidentical allogeneic hematopoietic transplantation: Developing a novel DRCI-based nomogram. Front Immunol 14:1128982. https://doi.org/10.3389/fimmu.2023.1128982
Article CAS PubMed PubMed Central Google Scholar
Magenau J, Couriel DR (2013) Hematopoietic stem cell transplantation for acute myeloid leukemia: to whom, when, and how. Curr Oncol Rep 15(5):436–444. https://doi.org/10.1007/s11912-013-0340-6
Article CAS PubMed Google Scholar
Dou L, Shi M, Song J, Niu X, Niu J, Wei S, Li D, Bai Y, Sun K (2022) The prognostic significance of C-reactive protein to albumin ratio in newly diagnosed acute myeloid leukaemia patients. Cancer Manag Res 14:303–316. https://doi.org/10.2147/CMAR.S343580
Article CAS PubMed PubMed Central Google Scholar
Cui X, Jia Z, Chen D, Xu C, Yang P (2020) The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis. Med (Baltim) 99(14):e19165. https://doi.org/10.1097/MD.0000000000019165
Yamamoto W, Fujii E, Matsumoto K, Yamamoto E, Aoki J, Tanaka M, Ishigatsubo Y, Kanamori H (2016) Prognostic value of pretransplant serum C-reactive protein in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Int J Hematol 103(4):444–452. https://doi.org/10.1007/s12185-016-1941-2
Article CAS PubMed Google Scholar
Soeters PB, Wolfe RR, Shenkin A, Hypoalbuminemia (2019) Pathogenesis and clinical significance. JPEN J Parenter Enter Nutr 43(2):181–193. https://doi.org/10.1002/jpen.1451
Kwon JW, Jeon Y, Jung HY, Choi JY, Park SH, Kim CD, Kim YL, Hwang D, Yun WS, Kim HK, Huh S, Yoo ES, Won DI, Cho JH, Lim JH (2023) Pretransplant C-reactive protein-to-albumin ratio predicts mortality in kidney transplant recipients: a retrospective cohort study. Korean J Transpl 37(1):19–28. https://doi.org/10.4285/kjt.22.0047
Jung J, Lee H, Heo JY, Chang MH, Lee E, Park WS, Park JH, Eom HS (2021) High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma. Sci Rep 11(1):2674. https://doi.org/10.1038/s41598-021-82087-6
Article CAS PubMed PubMed Central Google Scholar
Miyashita E, Konuma T, Kataoka J, Oiwa-Monna M, Mizusawa M, Isobe M, Kato S, Sato T, Takahashi S, Tojo A (2019) The prognostic impact of pretransplantation inflammatory and nutritional status in adult patients after myeloablative single cord blood transplantation. Biol Blood Marrow Transpl 25(5):981–988. https://doi.org/10.1016/j.bbmt.2019.01.006
Schaffrath J, Diederichs T, Unverzagt S, Wass M, Gläser U, Weber T, Binder M, Müller-Tidow C, Müller LP (2022) Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation. Ann Hematol 101(3):681–691. https://doi.org/10.1007/s00277-021-04736-0
Article CAS PubMed Google Scholar
Zhou T, Zhan J, Hong S, Hu Z, Fang W, Qin T, Ma Y, Yang Y, He X, Zhao Y, Huang Y, Zhao H, Zhang L (2015) Ratio of C-reactive protein/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer. Sci Rep 5:10481. https://doi.org/10.1038/srep10481
Article PubMed PubMed Central Google Scholar
Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, Fushiya N, Koike K, Nishino H, Matsushima M (2015) The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol 22(3):803–810. https://doi.org/10.1245/s10434-014-4048-0
Cao X, Cui J, Li Z, Zhao G (2021) Preoperative C-reactive protein/albumin ratio is a prognostic indicator for survival in surgically treated gastrointestinal stromal tumors: A retrospective cohort study. Cancer Manag Res 13:4155–4167. https://doi.org/10.2147/CMAR.S307873
Article CAS PubMed PubMed Central Google Scholar
Park JE, Chung KS, Song JH, Kim SY, Kim EY, Jung JY, Kang YA, Park MS, Kim YS, Chang J, Leem AY (2018) The C-reactive protein/albumin ratio as a predictor of mortality in critically ill patients. J Clin Med 7(10):333. https://doi.org/10.3390/jcm7100333
Article CAS PubMed PubMed Central Google Scholar
Kawano N, Shimonodan H, Nagahiro Y, Yoshida S, Kuriyama T, Takigawa K, Tochigi T, Nakaike T, Makino S, Yamashita K, Marutsuka K, Ochiai H, Mori Y, Shimoda K, Ohshima K, Mashiba K, Kikuchi I (2023) The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL). J Clin Exp Hematop 63(2):73–82. https://doi.org/10.3960/jslrt.22039
Article PubMed PubMed Central Google Scholar
Jung J, Heo JY, Lee E, Lee H, Chang MH, Park JH, Eom HS (2023) Pretreatment C-reactive protein-to-albumin ratio predicts clinical outcomes in patients with peripheral T-cell lymphoma. Int J Hematol 117(2):216–224. https://doi.org/10.1007/s12185-022-03474-x
Article CAS PubMed Google Scholar
Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M (2009) Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transpl 15(12):1628–1633. https://doi.org/10.1016/j.bbmt.2009.07.004
Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M, ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN (2013) European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 98(12):1826–1835. https://doi.org/10.3324/haematol.2013.091025
Article PubMed PubMed Central Google Scholar
Maertens JA, Girmenia C, Brüggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C (2018) European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN). European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J Antimicrob Chemother 73(12):3221-30. https://doi.org/10.1093/jac/dky286
Ljungman P, de la Camara R, Robin C, Crocchiolo R, Einsele H, Hill JA, Hubacek P, Navarro D, Cordonnier C, Ward KN (2017) European Conference on Infections in Leukaemia group. Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis 2019;19(8):e260-72. https://doi.org/10.1016/S1473-3099(19)30107-0
Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E (2016) Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transpl 51(7):906–912. https://doi.org/10.1038/bmt.2016.130
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME. 21(3):389–401.e1. https://doi.org/10.1016/j.bbmt.2014.12.001
Kim KS, Kwon HM, Kim JH, Yang JW, Jun IG, Song JG, Hwang GS (2015) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. C-reactive protein-to-albumin ratio is a predictor of 1-year mortality following liver transplantation. Anesth Pain Med (Seoul) 2022;17(4):420-8. https://doi.org/10.17085/apm.22176
Senjo H, Onozawa M, Hidaka D, Yokoyama S, Yamamoto S, Tsutsumi Y, Haseyama Y, Nagashima T, Mori A, Ota S, Sakai H, Ishihara T, Miyagishima T, Kakinoki Y, Kurosawa M, Kobayashi H, Iwasaki H, Hashimoto D, Kondo T, Teshima T (2022) High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia. Sci Rep 12(1):8885. https://doi.org/10.1038/s41598-022-12813-1
Article CAS PubMed PubMed Central Google Scholar
Tang HN, Pan BH, Wang L, Zhu HY, Fan L, Xu W, Li JY (2021) C-reactive protein-to-albumin ratio is an independent poor prognostic factor in newly diagnosed chronic lymphocytic leukaemia: A clinical analysis of 322 cases. Transl Oncol 14(4):101035. https://doi.org/10.1016/j.tranon.2021.101035
Article CAS PubMed PubMed Central Google Scholar
Di QS, Xu T, Song Y, Zuo ZG, Cao FJ, Yu XJ, Tang JY, Zhang W, Li C, Wan GX, Cai XJ (2020) High C-reactive protein to albumin ratio predicts inferior clinical outcomes in extranodal natural killer T-cell lymphoma. Dose Response 18(2):1559325820917824. https://doi.org/10.1177/1559325820917824
Article CAS PubMed PubMed Central Google Scholar
Lucijanic M, Galusic D, Krecak I, Sedinic M, Soric E, Holik H, Perisa V, Moric Peric M, Zekanovic I, Stoos-Veic T, Kusec R (2020) C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis. Leuk Lymphoma 61(12):2969–2974. https://doi.org/10.1080/10428194.2020.1789627
Article CAS PubMed Google Scholar
Brauer D, Backhaus D, Pointner R, Vucinic V, Niederwieser D, Platzbecker U, Schwind S, Jentzsch M (2021) Nutritional status at diagnosis and pre-transplant weight loss impact outcomes of acute myeloid leukemia patients following allogeneic stem cell transplantation. Hemasphere 5(3):e532. https://doi.org/10.1097/HS9.0000000000000532
留言 (0)